Table 5.
Susceptibility of P. aeruginosa colonies beneath mucin, alginate, or alginate and mucin barriers with external magnetic field application
| Disk no. compound | Mucin barrier | Alginate barrier | Mucin + alginate barriers |
|---|---|---|---|
| 1. Fe3O4 NPs† 10 μg | 30/I | 0/R | 20/S |
| 2. Fe3O4 @ALG:TOBRA | 25/R | 19/R | 14/R |
| 3. Tobramycin* | 0 R | 0/R | 0/R |
| 4. Tobramycin 100 μg** | 10/R** | 12/R** | 0/R** |
| 5. Tobramycin 200 mg** | 32/R** | 30/R** | 20/R** |
Disk diffusion method was used. Minimum concentrations demonstrating susceptibility in previous disk diffusion studies were used for NPs and NP-tobramycin conjugates. †Uncapped NPs, ALG alginate, TOBRA tobramycin
* Maximum CLSI cutoff concentration for susceptibility of tobramycin 10 μg absorbed onto disk
** Corresponding to experimentally determined susceptibility, these doses of tobramycin were up to five orders of magnitude higher than the CLSI standard dose for disk diffusion. Therefore, these colonies were tobramycin resistant by CLSI standard